Nevirapina Normon (Nevirapine)

Nevirapine, the active ingredient in Nevirapina Normon, is a Non-nucleoside reverse transcriptase inhibitor (NNRTI) presented as an oral tablet for oral use. It is used to treat HIV-1 infection in adults, adolescents and children. GNH USA supplies Nevirapina Normon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nevirapine is an antiretroviral drug that targets HIV‑1 reverse transcriptase and is employed in combination therapy for HIV infection. - Adult HIV‑1 infection: reduces viral load and improves immune function when used with other antiretrovirals. - Adolescent HIV‑1 infection: part of combination regimens to control viral replication in patients aged 12‑17. - Pediatric HIV‑1 infection (≥2 years): used with other agents to suppress HIV‑1 in children.

Nevirapine may cause a range of adverse reactions, from mild to severe.

Common Side Effects: - Rash: mild to moderate skin eruptions. - Nausea: occasional gastrointestinal upset. - Headache: transient cranial discomfort. - Fatigue: feeling of tiredness. - Abdominal pain: mild stomach discomfort. - Dizziness: occasional light‑headedness.

Serious or Rare Side Effects: - Stevens‑Johnson syndrome: severe skin reaction requiring immediate medical attention. - Hepatic failure: signs of liver injury such as jaundice. - Severe hypersensitivity: systemic allergic response. - Hepatotoxicity: elevated liver enzymes or liver inflammation. - Life‑threatening skin reactions: toxic epidermal necrolysis. - Severe anemia: marked reduction in red blood cells.

Before initiating therapy, clinicians should assess patient history and monitor for specific risks. - Liver function monitoring: check baseline enzymes and repeat periodically. - Hypersensitivity assessment: avoid in patients with known nevirapine allergy. - CD4 count evaluation: higher risk of rash in women with CD4 >250 cells/µL. - Counseling on rash: advise patients to report any skin changes promptly. - Pregnancy considerations: use only if benefits outweigh potential risks. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Nevirapine interacts with several medicines that can alter its effectiveness or increase toxicity.

Major Interactions (Avoid): - Ritonavir‑boosted protease inhibitors: can significantly increase nevirapine levels. - St. John’s wort: induces metabolism, reducing nevirapine exposure. - Carbamazepine: strong enzyme inducer that lowers nevirapine concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: may require INR monitoring due to altered anticoagulant effect. - Oral contraceptives: efficacy may be reduced, consider alternative contraception. - Nephrotoxic drugs: monitor renal function when used together.